ArticleAlzheimer's research & therapy2021

The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status.

Michael Ouk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.